Federal Policy Changes and Online Diversity, Equity, and Inclusion Content Among US Medical Schools.
Sreepada S, Ko M.
europepmc +1 more source
AI Applications Integrating Legal and Regulatory Perspectives in Mental Health: Systematic Review. [PDF]
Kandeel ME +7 more
europepmc +1 more source
‘Shelter is a Dignity’: Rental Racism, Stress and Housing (In)justice
ABSTRACT Australia's private rental sector is in crisis, and culturally and racially minoritised renters face compounded harms through both covert and everyday direct forms of rental racism. Drawing on five community‐based focus groups in Melbourne (n = 37), the paper explores how racism manifests across the rental pathway and how it structures the ...
Erika Martino +3 more
wiley +1 more source
Curriculum framework for artificial intelligence literacy in veterinary education. [PDF]
Huang YT, Chu CP.
europepmc +1 more source
ABSTRACT Nations manufacture non‐belonging of temporary migrants through policy frameworks that produce exclusion. This precarity maximises the economic benefit of temporary migrant labour by minimising their political, social and legal rights. In this paper, we examine how non‐belonging targeting Working Holiday Makers (WHMs) is manufactured in ...
Donna James, Alanna Kamp
wiley +1 more source
Tackling Administrative Burden in Graduate Medical Education: Consider AI-Powered Tools. [PDF]
Phung JY, Chung AD, Kwan BY.
europepmc +1 more source
A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE
Objective Autoimmune encephalitis (AIE) has long‐lasting effects. Generic clinical assessment‐scales insufficiently capture disease‐specific sequelae. Patient‐reported outcome measures (PROMs) assess outcomes important to patients, ensuring relevance in the clinic and trials.
Juliette Brenner +24 more
wiley +1 more source
Barriers and facilitators to healthcare access among Sub-Saharan African migrants in Europe: A scoping review. [PDF]
Cynthia AN +5 more
europepmc +1 more source
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment
Objective The antisense oligonucleotide tofersen is the first disease‐modifying drug for SOD1‐related amyotrophic lateral sclerosis (ALS) and was approved because of its ability to reduce SOD1 protein and neurofilament levels. The effect of tofersen on SOD1 activity is unclear but of clinical relevance because homozygous SOD1 mutations, linked to ...
Katharina Goehring +18 more
wiley +1 more source
Editorial: The emerging role of large language model chatbots in gastroenterology and digestive endoscopy. [PDF]
Gravina AG, Pellegrino R, Zagari RM.
europepmc +1 more source

